PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'University Hospitals Leuven (UZ Leuven), Leuven, Belgium. timothy.devos@uzleuven.be.\', \'Catholic University of Leuven (KU Leuven), Leuven, Belgium. timothy.devos@uzleuven.be.\', \'University Hospitals Leuven (UZ Leuven), Leuven, Belgium.\', \'Catholic University of Leuven (KU Leuven), Leuven, Belgium.\', \'Universitair Ziekenhuis Gent, Ghent, Belgium.\', \'Instituut voor Tropische Geneeskunde, Antwerp, Belgium.\', \'Sciensano, Elsene, Belgium.\', \'Rode Kruis Vlaanderen, Mechelen, Belgium.\', \'Universite Libre de Bruxelles Institut d\'Immunologie Medicale, Bruxelles, Belgium.\', \'Universite de Liege, Liege, Belgium.\', \'Universite Libre de Bruxelles, Bruxelles, Belgium.\', \'Leuven Coordinating Centre, Leuven, Belgium.\', \'Katholieke Universiteit Leuven Rega Institute for Medical Research, Leuven, Belgium.\', \'Universitair Ziekenhuis Brussel, Bruxelles, Belgium.\', \'Croix Rouge de Belgique, Bruxelles, Belgium.\', \'Interuniversity Institute for Biostatistics and statistical Bioinformatics, Leuven, Belgium.\', \'Universitair Ziekenhuis Antwerpen, Antwerpen, Belgium.\', \'Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe, Belgium.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s13063-020-04876-0
?:hasPublicationType
?:journal
  • Trials
is ?:pmid of
?:pmid
?:pmid
  • 33246499
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.291
?:rankingScore_hIndex
  • 57
is ?:relation_isRelatedTo_publication of
?:title
  • A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33246499>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33246499>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all